Skip to main
  1. Stocks
  2. Genmab - ADR
  3. Market Cap
GMAB

GMAB Market Capitalization Overview

Market Cap: $33.13B as of Nov 11, 2026

$33.13B
$10.98B (49.55%)past month
As of Nov 11, 2026, GMAB has a market capitalization of $33.13B. Over the past 30 days, its market cap has increased by 58.96%, while in the last 12 months, it has increased by 74.61%.

Market capitalization represents the total value of Genmab - ADR as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

GMAB Market Cap Formula = Stock Price * Shares Outstanding

The market cap of GMAB helps investors assess the company's size and compare it with competitors for better investment decisions.

GMAB Market Cap & Key Trends

See Genmab - ADR’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.

Start investing in GMAB

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

GMAB Market Cap History

DateMarket CapChange
Nov 2, 2026$32.82B+58.96%
Oct 1, 2026$20.65B+3.88%
Sep 1, 2026$19.88B+16.48%
Aug 3, 2026$17.07B+3.76%
Jul 1, 2026$16.45B+8.61%
Jun 1, 2026$15.15B-4.17%
May 1, 2026$15.80B-5.82%
Apr 1, 2026$16.78B-8.18%
Mar 2, 2026$18.28B-10.85%
Feb 2, 2026$20.50B+4.56%
Jan 2, 2026$19.61B+1.37%

GMAB End of Year Market Cap History

DateMarket CapChange
2026$33.13B+74.61%
2025$18.98B+43.11%
2024$13.26B-36.26%
2023$20.80B-24.92%
2022$27.71B+7.03%
2021$25.89B—

FAQs About Genmab - ADR (GMAB) Market Cap

As of Nov 11, 2026, the market capitalization of GMAB is $33.13B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Genmab - ADR’s market capitalization has increased by 49.55%, changing from $22.16B to $33.13B as of Nov 11, 2026.

In the last 3 months, Genmab - ADR’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Genmab - ADR’s market capitalization increased from $13.26B in January to $18.98B in December, reflecting a 43.11% change.

In the past five years, GMAB has had a compound annual growth rate (CAGR) of -6.02% in market capitalization. This means its market cap has shrunk at an average rate of -6.02% per year.

Genmab - ADR (GMAB)


GMAB Market Cap & Key Trends

See Genmab - ADR’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.

Start investing in GMAB

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover GMAB stock data and trends